This document summarizes a study investigating the potential protective role of ivermectin in acute lung injury (ALI) using lipopolysaccharide (LPS)- or bleomycin (BLM)-induced mouse models. The study found that ivermectin administration at doses of 1-2 mg/kg preserved alveolar structure and reduced inflammation, hemorrhage, and edema in the lungs of LPS- or BLM-treated mice. Ivermectin also inhibited neutrophil infiltration, myeloperoxidase activity, and phosphorylation of JNK and p38 MAPK proteins involved in inflammation. The results suggest ivermectin has strong anti-inflammatory effects and may help mitigate ALI by